Physician profile
Kristin D Will
NPI 1891958682
$1,082.93
in general payments reported to CMS, 2019-2025
12 companies · $301 in 2025
The $301 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.71 · 2020: $12.71 · 2022: $48.28 · 2023: $166 · 2024: $477 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $477.06 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $207.71 | 2023-2025 | Qelbree, Qelbree |
| Pfizer INC. | $92.69 | 2019-2025 | |
| Tris Pharma INC | $63.46 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $62.78 | 2024 | |
| Collegium Pharmaceutical, INC. | $61.85 | 2025 | Jornay Pm |
| Novo Nordisk INC | $31.82 | 2023 | |
| Abbott Laboratories | $20.86 | 2023 | Freestyle Libre 2 |
| Kyowa Kirin, INC. | $19.82 | 2024 | Crysvita |
| Biomarin Pharmaceutical INC. | $17.87 | 2024 | Voxzogo 1.2mg |
| Lilly USA, LLC | $14.76 | 2023 | Emgality, Jardiance |
| Glaxosmithkline, LLC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Will listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.